CSL - Operating Expenses


CSL reported $5.7B in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Alterity Therapeutics Limited AUD 8.67M 893.38K Dec/2025
Arca Biopharma USD 36.43M 2M Mar/2026
aTyr Pharma USD 2.42M 83.19M Mar/2026
Bio Path USD 297K 191K Mar/2026
Brainstorm Cell Therapeutics USD 2.05M 198K Mar/2026
Cara Therapeutics USD 7.05M 1.11M Mar/2026
CSL USD 5.7B 2.82B Dec/2025
Curis USD 11.52M 2.5M Mar/2026
Immunic USD 23.33M 2.67M Dec/2025
Minerva Neurosciences USD 4.52M 155.46K Dec/2024
Sangamo BioSciences USD 33.87M 12.89M Jun/2024
TherapeuticsMD USD 1.41M 50K Jun/2024